 (OTC Bulletin Board: PBME), which provides specialty reference biomarker services to support pharmaceutical and laboratory diagnostic manufacturers in the conduct of human clinical research, announced that its corporate name has been officially changed to Pacific Biomarkers, Inc. The name was approved by shareholders and the State of Washington in December 2009. At the present time, the Company is waiting for a pending change in its stock symbol. In the meantime, the shares continue to trade on the OTC Bulletin Board under the symbol "PBME".